Victoria Thieberger
All Stories

CVC, Goldman eye $3.8 billion debt-for-equity swap for Australia’s Nine: sources
MELBOURNE (Reuters) - Goldman Sachs and private equity firm CVC Capital Partners Ltd have proposed a debt-for-equity swap for CVC's Australian television network Nine, two sources said on Monday, a...

CVC, Goldman eye $3.8 billion debt-for-equity swap for Australia’s Nine: sources
MELBOURNE (Reuters) - Goldman Sachs and private equity firm CVC Capital Partners Ltd have proposed a debt-for-equity swap for CVC's Australian television network Nine, two sources said on Monday, a...

Australia’s Cochlear plans to return implant to market
MELBOURNE (Reuters) - Cochlear Ltd, the world's biggest maker of hearing implants, pledged on Tuesday to relaunch its top-selling implant after pulling it from the market due to a manufacturing...

Australia’s Cochlear plans to return implant to market
MELBOURNE (Reuters) - Cochlear Ltd, the world's biggest maker of hearing implants, pledged on Tuesday to relaunch its top-selling implant after pulling it from the market due to a manufacturing...

TPG eyes $3 billion joint bid for Australia’s Nine: sources
MELBOURNE/SYDNEY (Reuters) - U.S. private equity firm TPG is considering partnering with a Hollywood media executive to bid for debt-laden Australian media company Nine Entertainment Co, sources said, in what...

TPG eyes $3 billion joint bid for Australia’s Nine: sources
MELBOURNE/SYDNEY (Reuters) - U.S. private equity firm TPG is considering partnering with a Hollywood media executive to bid for debt-laden Australian media company Nine Entertainment Co, sources said, in what...

New Zealand firm to trial pig cells to treat Parkinson’s
MELBOURNE (Reuters) - A New Zealand company plans to implant pig cells in the human brain in a clinical trial to treat Parkinson's disease and help improve movement and brain...

New Zealand firm to trial pig cells to treat Parkinson’s
MELBOURNE (Reuters) - A New Zealand company plans to implant pig cells in the human brain in a clinical trial to treat Parkinson's disease and help improve movement and brain...
